Personalized Noninvasive Support in Acute Hypoxemic Respiratory Failure

NCT06202144 — Not applicable, Completed, 20 participants, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Physiological Effects of Personalized Noninvasive Support in Acute Hypoxemic Respiratory Failure

RegistryNCT06202144
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, crossover, masking: none, treatment
Enrollment20 (Actual)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS (Other)
ConditionsAcute Hypoxic Respiratory Failure
InterventionsNoninvasive support (Device)
Datesstart 2024-01-12, primary completion 2025-06-01, completion 2025-06-15, first posted 2024-01-11, last updated 2025-09-30
Locations1 site in Italy

Related Papers Related Patents Related Grants Related Experts
All trials for Acute Hypoxic Respiratory Failure All trials of Noninvasive support

-Summary

The optimal noninvasive respiratory support for acute hypoxemic respiratory failure is debated. Recent preliminary data indicate that both pressure-support noninvasive ventilation (NIV) and continuous-positive airway pressure (CPAP) may be of benefit. While often applied interchangeably in clinical practice, NIV and CPAP have different effects on the inspiratory effort, which is the major determinant of self-inflicted lung injury. Also, inspiratory effort widely varies among individuals.

The purpose of this study is to assess the physiological effects of a noninvasive respiratory support approach guided by inspiratory effort, as compared to CPAP and NIV, in patients with moderate-to-severe acute hypoxemic respiratory failure.

Expand all sections  ·  Collapse all

+Detailed description

Patients with acute hypoxemic respiratory failure will undergo a decremental pressure-support trial during helmet noninvasive support. The following pressure-support settings will be applied sequentially, with positive end-expiratory pressure kept constant and equal to 10-12 cmH2O: 20 cmH2O, 16 cmH2O, 12 cmH2O, 8 cmH2O and high-flow-driven CPAP. Inspiratory effort will be monitored during the trial through esophageal manometry. The personalized setting of noninvasive support will be defined as the minimal pressure-support level capable of generating inspiratory effort between 5 and 10 cmH2O.

Personalized noninvasive support will be then compared to conventionally-set NIV and CPAP in a randomized cross-over trial.

+Arms and interventions

ArmTypeInterventionsDescription
Personalized Noninvasive supportExperimentalDevice: Noninvasive supportHelmet noninvasive support, with positive end-expiratory pressure (PEEP)=12 cmH2O and the minimal pressure-support level capable of generating inspiratory effort between 5 and 10 cmH2O
Continuous positive airway pressureActive comparatorDevice: Noninvasive supportHelmet CPAP will be delivered through a high-flow generator and PEEP valve set at 12 cmH2O
Noninvasive ventilationActive comparatorDevice: Noninvasive supportHelmet NIV will be delivered in the pressure-support mode, with PEEP=12 cmH2O and pressure support=12 cmH2O
  • Noninvasive support (Device): Noninvasive respiratory support delivered through a helmet

+Outcome measures

Primary outcomes

  • Tidal volume [1 hour]: Tidal volume size, assessed with electrical impedance tomography
  • Transpulmonary driving pressure [1 hour]: The positive inspiratory swing in transpulmonary pressure, calculated as airway pressure minus esophageal pressure

Secondary outcomes

  • Inspiratory effort [1 hour]: Inspiratory effort, defined as the negative deflection in esophageal pressure
  • Respiratory rate [1 hour]: Respiratory rate per minute
  • Blood oxygenation [1 hour]: PaO2/FiO2 ratio
  • Work of breathing [1 hour]: Simplified esophageal pressure pressure-time product
  • Corrected minute ventilation [1 hour]: Minute ventilation (assessed with electrical impedance tomography) normalized to PaCO2
  • Tidal volume distribution [1 hour]: Tidal volume distribution in the four lung regions of interest (ventral, mid-ventral, mid-dorsal and dorsal), assessed with electrical impedance tomography
  • End-expiratory lung impedance [1 hour]: End-expiratory lung impedance, assessed with electrical impedance tomography
  • Pendelluft extent [1 hour]: Pendelluft, assessed with electrical impedance tomography and expressed in % of tidal volume size
  • Lung compliance [1 hour]: Defined as the ration of tidal volume to transpulmonary driving pressure
  • Dyspnea [1 hour]: Dyspnea, defined through a visual analog scale ((ranging from 0 to 10, with representing most severe dyspnea)

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Acute hypoxemic respiratory failure and PaO2/FiO2<200 mmHg
* PaCO2<45 mmHg
* Respiratory failure not caused by exacerbation of chronic pulmonary disease, cardiac failure or fluid overload

Exclusion Criteria:

* Pregnancy
* Contraindication to helmet support
* Contraindication to esophageal manometry
* Contraindication to electrical-impedance tomography monitoring
* Recent surgery involving the abdomen or the thorax
* Pneumothorax or documented barotrauma

+Locations (1)

FacilityCityCountryStatus
Fondazione Policlinico Universitaro A. Gemelli IRCCSRomeItaly

+Investigators

  • Domenico Luca Grieco, Principal investigator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS